Using CRISPR/Cas9 to Edit Disease Out of the Genome
Type
Blog Post
Published
June 23, 2022, 1:15 p.m.
...several treatments are currently being tested in clinical trials. It is speeding the process of the discovery...saw these two papers,” said the University of California Berkeley’s Jennifer Doudna. “They are the first...continue to be a primary preoccupation of her California lab and many others. “Those off-target effects...cleavage sites are repaired.” Those insights will be critical for scientists’ ability to influence editing efficiency...Application in Genetic Diseases: A Review.” Current pharmaceutical biotechnology. https://doi.org/10.2174/1389201021666200621161610...